Biomedical Catalyst 2022: Round 2

Innovate UK have announced the funding competition for Biomedical Catalyst 2022 Round 2. The Biomedical Catalyst programme was established in 2012 and supports pre-market R&D projects in which UK registered businesses can apply for a share of £25 million to invest in their project. Targeting innovative solutions for health and healthcare challenges, applications must demonstrate evidence of commercial and technical feasibility.

The BMC funding opportunity will cover projects with a total cost of £150k up to £4 million, with a maximum grant of £2 million or up to 70% of the eligible project costs. The deadline for applications is the 12th of October 2022 with applicants being notified of the outcome on the 27th January.

The funding is targeted to support a variety of projects, markets and technologies. In summary, the funding would cover: experimental evaluation, use of models to demonstrate proof of concept, prototyping, IP. The project could also include a demonstration of clinical effectiveness, comprising identifying clinical claims and benefits, clinical investigation studies and regulatory planning, for example, preliminary or development CERs.

If you would like to find out more, require support with your application, defining the project milestones or work packages; please get in contact with the Innovation Team at Medilink via email [email protected] or phone 0114 232 9292.